BORGESON BLAKE sold 3.3% of their position (220K shares) of RECURSION PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $924.0K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 2/6/2026ACC: 0001601830-26-000007
Director
Since Apr 2021
-220K
Net shares
Net seller
$924.0K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
220K disposed
Non-Derivative Transactions1
Class A Common Stock
Direct
Shares
−220K
Price / share
$4.20
Trade value
$924K
% of position
3.3%
2/3/2026
6.65M→6.43M
Total
Net shares
−220K
Net value
-$924K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock Direct | 2/3/2026 | S · Sale | −220K | $4.20 | $924K | 3.3% | 6.65M | 6.43M |
| Total | −220K | -$924K | ||||||
Derivative Transactions0
No derivative transactions reported